{
  "pmid": "28010010",
  "uid": "28010010",
  "title": "HOPE-â€‘3, BP treatment, milestones in CV prevention. Dr. Salim Yusuf in an interview with Dr. Akbar Panju and Dr. Roman Jaeschke.",
  "abstract": "",
  "authors": [
    {
      "last_name": "Yusuf",
      "fore_name": "Salim",
      "initials": "S",
      "name": "Salim Yusuf",
      "affiliations": []
    },
    {
      "last_name": "Panju",
      "fore_name": "Akbar",
      "initials": "A",
      "name": "Akbar Panju",
      "affiliations": []
    },
    {
      "last_name": "Jaeschke",
      "fore_name": "Roman",
      "initials": "R",
      "name": "Roman Jaeschke",
      "affiliations": []
    }
  ],
  "journal": {
    "title": "Polskie Archiwum Medycyny Wewnetrznej",
    "iso_abbreviation": "Pol Arch Med Wewn",
    "volume": "126",
    "issue": "12",
    "pub_year": "2016",
    "pub_month": "Dec",
    "pub_day": "23"
  },
  "start_page": "1033",
  "end_page": "1035",
  "pages": "1033-1035",
  "language": "eng",
  "publication_types": [
    "Interview"
  ],
  "keywords": [
    "Antihypertensive Agents",
    "Cardiovascular Diseases",
    "Clinical Trials as Topic",
    "Drug Therapy, Combination",
    "Humans",
    "Hydroxymethylglutaryl-CoA Reductase Inhibitors",
    "Hyperlipidemias",
    "Hypertension",
    "Practice Guidelines as Topic",
    "Treatment Outcome"
  ],
  "article_ids": {
    "pubmed": "28010010",
    "doi": "10.20452/pamw.3765"
  },
  "doi": "10.20452/pamw.3765",
  "dates": {
    "completed": "2017-04-25",
    "revised": "2017-08-17"
  },
  "chemicals": [
    "Antihypertensive Agents",
    "Hydroxymethylglutaryl-CoA Reductase Inhibitors"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T15:11:42.722251",
    "pmid": "28010010"
  }
}